- Home
- CGC vs EICB Comparison
CGC vs EICB Comparison
Compare CGC & EICB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CGC | EICB |
|---|---|---|
| Founded | N/A | N/A |
| Country | Canada | |
| Employees | N/A | N/A |
| Industry | Pharmaceuticals and Biotechnology | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 578.3M | N/A |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | CGC | EICB |
|---|---|---|
| Price | $1.27 | $25.00 |
| Analyst Decision | Hold | |
| Analyst Count | 2 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 52.3M | N/A |
| Earning Date | 02-06-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $200,022,256.00 | N/A |
| Revenue This Year | $6.79 | N/A |
| Revenue Next Year | $7.34 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.77 | N/A |
| 52 Week High | $3.07 | N/A |
Technical Indicators
Market Signals| Indicator | CGC | EICB |
|---|---|---|
| Relative Strength Index (RSI) | 46.92 | 41.00 |
| Support Level | $1.54 | $24.96 |
| Resistance Level | $2.38 | $25.00 |
| Average True Range (ATR) | 0.24 | 0.04 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 13.57 | 38.10 |
Price Performance
Historical ComparisonAbout CGC Canopy Growth Corporation
Canopy Growth Corp, cultivates and sells medicinal and recreational cannabis and hemp through a portfolio of brands that include Doja, LivRelief, Ace Valley, Deep Space, and others. The Company is engaged in reportable segments namely: Canada cannabis, International markets cannabis, Storz & Bickel, and This Works. The company generates maximum revenue from Canadian cannabis.
About EICB Eagle Point Income Company Inc. 7.75% Series B Term Preferred Stock Due 2028
Eagle Point Income Co Inc is a closed-end management investment company. Its primary investment objective is to generate high current income, with a secondary objective to generate capital appreciation. The Company seeks to achieve its investment objectives by investing in junior debt tranches of collateralized loan obligations, or "CLOs," that are collateralized by a portfolio consisting of below-investment grade U.S. senior secured loans with a large number of distinct underlying borrowers across various industry sectors.